Is HPV DNA testing specificity comparable to that of cytological testing in primary cervical cancer screening? Results of a meta-analysis of randomized controlled trials

Randomized controlled trial of human pap

Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST)

✍ Marie-Hélène Mayrand; Eliane Duarte-Franco; François Coutlée; Isabel Rodrigues; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 403 KB 👁 1 views

## Abstract Since infection with oncogenic human papillomavirus (HPV) has been considered a necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as adjuncts or replacements to Pap cytology. We designed the Canadian Cervical Cancer Screening Trial (CCCaST) to compare